US6319914B1
(en)
*
|
1993-11-05 |
2001-11-20 |
Apollo Biopharmaceuticals, Inc. |
Cytoprotective effect of polycyclic phenolic compounds
|
US6350739B1
(en)
*
|
1999-08-11 |
2002-02-26 |
University Of Florida Resarch Foundation, Inc. |
Methods of prevention and treatment of ischemic damage
|
US5877169A
(en)
*
|
1993-11-05 |
1999-03-02 |
University Of Florida Research Foundation, Inc. |
Methods of treatment of ischemic damage
|
DE4338314C1
(en)
|
1993-11-10 |
1995-03-30 |
Jenapharm Gmbh |
Pharmaceutical preparations for the prophylaxis and therapy of radical-mediated cell damage
|
US5550029A
(en)
*
|
1994-09-08 |
1996-08-27 |
University Of Florida |
Method for diagnosing estrogen responsiveness
|
WO1996022091A1
(en)
*
|
1995-01-20 |
1996-07-25 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
|
FR2754179B1
(en)
*
|
1996-10-08 |
1998-12-24 |
Theramex |
NOVEL HORMONONAL COMPOSITION AND ITS USE
|
US6015786A
(en)
*
|
1997-02-25 |
2000-01-18 |
Celtrix Pharmaceuticals, Inc. |
Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
|
EP0983382A1
(en)
*
|
1997-03-24 |
2000-03-08 |
Spectra Biomedical |
Estrogen and the mental state: molecular variations within the estrogen receptor gene modulate clinical susceptibility to depression
|
WO1998043647A1
(en)
|
1997-03-28 |
1998-10-08 |
Massachusetts Institute Of Technology, Inc. |
Regulation of amyloid precursor protein (app) expression by estrogenic compounds
|
JP2001517617A
(en)
*
|
1997-09-24 |
2001-10-09 |
ノヴァ モレキュラー インク. |
Methods for increasing APOE levels for the treatment of neurodegenerative diseases
|
DE19821831A1
(en)
*
|
1998-05-15 |
1999-11-18 |
Jenapharm Gmbh |
Selectively supplementing estrogen deficiency in the central nervous system, using 14,15-cyclopropano estrane steroid compounds
|
CN1291102A
(en)
*
|
1998-02-20 |
2001-04-11 |
耶拿制药两合公司 |
Pharmaceutical preparation for selectively supplementing oestrogen deficiency in the central nervous system
|
US6245756B1
(en)
|
1998-02-27 |
2001-06-12 |
Jenapharm Gmbh & Co. Kg |
Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system
|
AU3221399A
(en)
*
|
1998-04-03 |
1999-10-25 |
Mcp Hahnemann University |
Neuron regulatory factor comprising a small peptide for promoting neuron survival
|
US6441049B2
(en)
*
|
1998-06-01 |
2002-08-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method of treating neurodegenerative disorders via inhibition of amyloid beta peptide binding
|
US6288108B1
(en)
|
1998-06-16 |
2001-09-11 |
Eli Lilly And Company |
Methods for increasing levels of acetylcholine
|
EA200100039A1
(en)
|
1998-06-16 |
2001-06-25 |
Эли Лилли Энд Компани |
METHODS OF INCREASING ACETYL CHOLINE LEVELS
|
WO1999066915A2
(en)
|
1998-06-23 |
1999-12-29 |
Southern Illinois University At Carbondale |
Therapeutic applications of estrogenic carboxylic acids
|
EP1121132A4
(en)
*
|
1998-10-07 |
2004-03-24 |
Univ Arkansas |
Method and compositions for increasing bone mass
|
US6660468B1
(en)
*
|
1998-10-27 |
2003-12-09 |
Board Of Trustees Of The University Of Arkansas |
Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
|
AU1525700A
(en)
|
1998-11-19 |
2000-06-05 |
Board Of Trustees Of The University Of Arkansas, The |
Increasing bone strength with selected bisphosphonates
|
US6326365B1
(en)
|
1999-07-20 |
2001-12-04 |
Apollo Biopharmaceutics, Inc. |
Methods of prevention and treatment of ischemic damage
|
US6339078B1
(en)
|
1999-07-20 |
2002-01-15 |
University Of Florida Research Foundation, Inc. |
Methods of prevention and treatment of ischemic damage
|
WO2001030356A1
(en)
|
1999-10-25 |
2001-05-03 |
Laboratoire Theramex |
Hormonal composition based on a progestational agent and an oestrogen and use thereof
|
AR027878A1
(en)
|
1999-11-05 |
2003-04-16 |
Wyeth Corp |
METHODS FOR IDENTIFYING AND USING AMILOID INHIBITING COMPOUNDS
|
US6265147B1
(en)
|
1999-12-01 |
2001-07-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of screening for neuroprotective agents
|
GB0003524D0
(en)
*
|
2000-02-15 |
2000-04-05 |
Btg Int Ltd |
Cytoprotective steroids (II)
|
US20030083277A1
(en)
*
|
2000-02-24 |
2003-05-01 |
Hersh Louis B. |
Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients
|
US20030165481A1
(en)
*
|
2000-02-24 |
2003-09-04 |
Hersh Louis B. |
Amyloid peptide inactivating enzyme to treat Alzheimer's disease
|
US20010034340A1
(en)
*
|
2000-03-20 |
2001-10-25 |
American Home Products Corporation |
Hormone replacement therapy
|
WO2001079299A1
(en)
|
2000-04-13 |
2001-10-25 |
The Rockefeller University |
Enhancement of antibody-mediated immune responses
|
AU2001269801A1
(en)
*
|
2000-06-13 |
2001-12-24 |
The Board Of Trustees For The University Of Arkansas |
Methods of dissociating nongenotropic from genotropic activity of steroid receptors
|
WO2002000619A2
(en)
*
|
2000-06-27 |
2002-01-03 |
University Of Florida Research Foundation, Inc. |
Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents
|
GB2363983A
(en)
*
|
2000-06-29 |
2002-01-16 |
Hunter Fleming Ltd |
Protection against neuronal damage using 7-hydroxyepiandrosterone
|
WO2002013870A2
(en)
*
|
2000-08-17 |
2002-02-21 |
Mitokor, Inc. |
Formulation for administering therapeutic lipophilic molecules
|
AU2002232509A1
(en)
*
|
2000-11-03 |
2002-05-15 |
Washington University |
Estrone-derivatives having cytoprotective activity
|
EP1834959B1
(en)
|
2000-11-03 |
2012-08-08 |
Washington University |
Tert-butyl-substituted aromatic steroids having cytoprotective activity
|
US20020132802A1
(en)
*
|
2000-11-17 |
2002-09-19 |
Washington Univeristy |
Cytoprotective polycyclic compounds
|
US20030013692A1
(en)
*
|
2001-01-19 |
2003-01-16 |
Gullans Steven R. |
Methods of treating neurological disorders
|
AU2002237126A1
(en)
*
|
2001-03-02 |
2002-09-19 |
Stem Cell Therapeutics Inc. |
Use of ovarian hormone for increasing neural stem cell number
|
WO2002069975A1
(en)
*
|
2001-03-02 |
2002-09-12 |
Stem Cell Therapeutics Inc. |
Use of estrogen to induce neural stem cell increase
|
WO2002074292A2
(en)
*
|
2001-03-16 |
2002-09-26 |
Wyeth |
Hormone replacement therapy
|
US20120328566A9
(en)
*
|
2001-04-25 |
2012-12-27 |
Rhonda R Voskuhl |
Estrogen receptor ligand treatment for neurodegenerative diseases
|
US8658627B2
(en)
*
|
2001-04-25 |
2014-02-25 |
The Regents Of The University Of California |
Pregnancy hormone combination for treatment of autoimmune diseases
|
US20120014915A9
(en)
*
|
2001-04-25 |
2012-01-19 |
Rhonda Voskuhl |
Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders
|
US20120322779A9
(en)
*
|
2001-04-25 |
2012-12-20 |
Rhonda Voskuhl |
Estriol Therapy for Autoimmune and Neurodegenerative Diseases and Disorders
|
US20130203722A1
(en)
|
2006-09-26 |
2013-08-08 |
Rhonda R. Voskuhl |
Estriol therapy for autoimmune and neurodegenerative disease and disorders
|
US6936599B2
(en)
|
2001-04-25 |
2005-08-30 |
The Regents Of The University Of California |
Estriol therapy for multiple sclerosis and other autoimmune diseases
|
US7488723B2
(en)
|
2001-09-05 |
2009-02-10 |
Alcon, Inc. |
Use of non-feminizing estrogens as treatment for retinal vascular diseases
|
US20040214806A1
(en)
*
|
2002-09-03 |
2004-10-28 |
Iok-Hou Pang |
Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
DE10157745A1
(en)
*
|
2001-11-24 |
2003-06-26 |
Hf Arzneimittelforsch Gmbh |
Transdermal therapeutic system for the administration of 17alpha-estradiol
|
WO2003047559A1
(en)
*
|
2001-12-05 |
2003-06-12 |
Mitokor, Inc. |
Use of polycyclic phenolic compounds for the treatment of opthalmic diseases
|
US6821979B2
(en)
*
|
2002-03-07 |
2004-11-23 |
Blanchette Rockefeller Neurosciences Institute |
Synergistic enhancement of cognitive ability
|
US7186707B2
(en)
|
2002-04-01 |
2007-03-06 |
University Of Florida |
Prodrugs for use as ophthalmic agents
|
US20070213310A1
(en)
*
|
2002-04-01 |
2007-09-13 |
Laszlo Prokai |
Prodrugs for Use as Ophthalmic Agents
|
US7300926B2
(en)
*
|
2002-04-01 |
2007-11-27 |
University Of Florida Research Foundation, Inc. |
Steroidal quinols and their use for estrogen replacement therapy
|
US7026306B2
(en)
*
|
2002-04-01 |
2006-04-11 |
University Of Florida Research Foundation, Inc. |
Steroidal quinols and their use for antioxidant therapy
|
TW200306196A
(en)
*
|
2002-04-03 |
2003-11-16 |
Wyeth Corp |
Hormone replacement therapy
|
TW200306846A
(en)
*
|
2002-04-03 |
2003-12-01 |
Wyeth Corp |
Hormone replacement therapy
|
TW200306851A
(en)
*
|
2002-04-29 |
2003-12-01 |
Wyeth Corp |
Hormone replacement therapy
|
WO2003097582A2
(en)
*
|
2002-05-15 |
2003-11-27 |
Genzyme Corporation |
Synthesis of benzonitriles and benzimidates
|
TW200400040A
(en)
*
|
2002-05-17 |
2004-01-01 |
Wyeth Corp |
Hormone replacement therapy
|
US20050074777A1
(en)
*
|
2002-09-24 |
2005-04-07 |
Toran-Allerand C. Dominique |
Novel cell-surface estrogen receptor and related compositions and methods
|
WO2004103288A2
(en)
*
|
2003-05-13 |
2004-12-02 |
New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Method of preventing recurrent miscarriages
|
US20060029597A1
(en)
*
|
2004-03-31 |
2006-02-09 |
Chimeric Technologies |
IgA antibody protein as a cytotoxic drug
|
WO2005116047A2
(en)
*
|
2004-05-27 |
2005-12-08 |
Migenix Corp. |
2-substituted 17-imino estrogen compounds for cytoprotection
|
EP1794322A4
(en)
|
2004-07-30 |
2009-10-28 |
Sinai School Medicine |
Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk
|
CA2579790A1
(en)
*
|
2004-07-30 |
2006-02-09 |
Mount Sinai School Of Medicine Of New York University |
Npc1l1 and npc1l1 inhibitors and methods of use thereof
|
US9044503B2
(en)
|
2004-08-27 |
2015-06-02 |
University Of Kentucky Research Foundation |
Amyloid peptide inactivating enzyme to treat alzheimer's disease peripherally
|
WO2006037107A2
(en)
*
|
2004-09-28 |
2006-04-06 |
The Board Of Trustees Of The Universtity Of Arkansas |
Methods of identifying glucocorticoids without the detrimental side effects of bone loss
|
WO2006042172A2
(en)
*
|
2004-10-09 |
2006-04-20 |
The Regents Of The University Of Michigan |
Gender differences in experimental aortic aneurysm formation
|
EP1825005B1
(en)
*
|
2004-11-24 |
2015-07-15 |
The Regents of the University of Colorado, a body corporate |
Mer diagnostic and therapeutic agents
|
AR055319A1
(en)
*
|
2005-03-17 |
2007-08-15 |
Wyeth Corp |
ISOQUINOLEIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
CA2623905A1
(en)
*
|
2005-09-26 |
2007-04-05 |
The Regents Of The University Of California |
Estriol therapy for autoimmune and neurodegenerative diseases and disorders
|
EP2698167A3
(en)
*
|
2005-09-26 |
2014-03-05 |
The Regents of The University of California |
Dosage form of an estriol and glatiramer acetate polymer-1 for the treatment of multiple sclerosis
|
ITMI20052377A1
(en)
*
|
2005-12-13 |
2007-06-14 |
Anna Petroni |
MEDICINATION BASED ON STEROID MONOESTER WITH LONG CHAIN FATTY ACIDS
|
AU2007205862A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Fred Mermelstein |
Method of treating atrophic vaginitis
|
EP1981540B1
(en)
*
|
2006-01-30 |
2013-03-20 |
Grifols Therapeutics Inc. |
Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
|
WO2008067387A2
(en)
*
|
2006-11-29 |
2008-06-05 |
Wyeth |
Estrogen/ serm and estrogen/ progestin bi-layer tablets
|
CL2008000095A1
(en)
*
|
2007-01-12 |
2008-05-16 |
Wyeth Corp |
COMPOSITION OF TABLET IN TABLET THAT INCLUDES A CENTRAL TABLET WITH STROGENS, A FILLER / DILUENT, A FILLER / BINDER, A POLYMER COMPONENT AND A LAYER OF EXTERNAL TABLET COMPRESSED WITH THERAPYUTICAL AGENTS / A FILLER
|
EP2114983B8
(en)
|
2007-02-07 |
2015-02-18 |
The Regents of the University of Colorado, A Body Corporate |
Axl tyrosine kinase inhibitors and methods of making and using the same
|
AR065816A1
(en)
*
|
2007-03-26 |
2009-07-01 |
Theramex |
ORAL CONTRACEPTIVE REGIME
|
US8093043B2
(en)
*
|
2008-06-04 |
2012-01-10 |
New York University |
β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
|
TW201127386A
(en)
|
2009-10-27 |
2011-08-16 |
Wyeth Llc |
Bazedoxifene formulations with antioxidants
|
PT2753355T
(en)
|
2011-09-08 |
2019-02-01 |
Univ New York |
Oncolytic herpes simplex virus and therapeutic uses thereof
|
US9555071B2
(en)
|
2012-06-13 |
2017-01-31 |
Thien Nguyen |
Methods and compositions for the treatment of axonal and neuronal degeneration
|
MA39818A
(en)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Exogenous tap inhibitor "armed" oncolytic viruses and therapeutic uses thereof
|
WO2016205429A1
(en)
|
2015-06-15 |
2016-12-22 |
New York University |
Method of treatment using oncolytic viruses
|